# Boston Scientific Corporation (BSX) — Q3-2016 Earnings Results

**Report date:** 2016-10-26 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2016

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 1.56%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.27 | N/A | +1.12% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management remains focused on strategic initiatives to drive future growth. However, they did not provide specific guidance for upcoming quarters.

**Key quotes:**

> Management expressed confidence in the company's long-term growth strategy.

> They highlighted ongoing investments in innovation and product development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a small beat on EPS, which indicates some positive momentum. However, the stock fell by 1.56% in reaction, likely due to the lack of revenue details and forward guidance. Investors may be cautious as they await more concrete information on the company's performance and strategy moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2016_